Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 22, 2026 08:29 ET | Source: Exubrion Therapeutics

Exubrion Therapeutics Promotes Gregory Taglialatela to Chief Commercial Officer

Exubrion Therapeutics®, the company behind Synovetin OA®, has promoted Gregory Taglialatela, MBA, to Chief Commercial Officer, effective July 1, 2026.